BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang X, Jin J, Li YX, Ren H, Fang H, Wang SL, Liu YP, Wang WH, Yu ZH, Song YW, Liu XF. Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer. World J Gastroenterol 2014; 20(4): 1067-1073 [PMID: 24574780 DOI: 10.3748/wjg.v20.i4.1067]
URL: https://www.wjgnet.com/1007-9327/full/v20/i4/1067.htm
Number Citing Articles
1
Xin Wang, Dong-Bing Zhao, Lin Yang, Yihebali Chi, Hong Zhao, Li-Ming Jiang, Jun Jiang, Yuan Tang, Ning Li, Wen-Yang Liu, Li-Zhou Dou, Shuang-Mei Zou, Li-Yan Xue, Jian-Song Ren, Yan-Tao Tian, Xu Che, Chun-Guang Guo, Xiao-Feng Bai, Yue-Min Sun, Shu-Lian Wang, Yong-Wen Song, Yue-Ping Liu, Hui Fang, Ye-Xiong Li, Jing Jin. Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized StudyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.870741
2
Meng Qiu, Xing-chen Peng, Feng Bi, Xin Wang, Qiu Li, Feng Xu, Zhi-ping Li, Ya-li Shen, Ji-yan Liu, Ya-qing Zhao, Dan Cao, Hong-feng Gou, Yu Yang, Ye Chen, Cheng Yi. Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancerMedical Oncology 2015; 32(7) doi: 10.1007/s12032-015-0635-6
3
X Wang, D B Zhao, L Yang, Y Chi, Y Tang, N Li, S L Wang, Y W Song, Y P Liu, W Y Liu, H Ren, T Zhang, J Y Wang, X S Chen, H Fang, W H Wang, Y X Li, J Jin. S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II studyBritish Journal of Cancer 2018; 118(3): 338 doi: 10.1038/bjc.2017.424
4
A. Schernberg, E. Rivin del Campo, B. Rousseau, O. Matzinger, M. Loi, P. Maingon, F. Huguet. Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectivesClinical and Translational Radiation Oncology 2018; 10: 13 doi: 10.1016/j.ctro.2018.02.005
5
Linda Agolli, Luca Nicosia. Between evidence and new perspectives on the current state of the multimodal approach to gastric cancer: Is there still a role for radiation therapy?World Journal of Gastrointestinal Oncology 2018; 10(9): 271-281 doi: 10.4251/wjgo.v10.i9.271
6
Xin Wang, Wei-Hu Wang, Shu-Lian Wang, Yong-Wen Song, Yue-Ping Liu, Yuan Tang, Ning Li, Wen-Yang Liu, Hui Fang, Ye-Xiong Li, Dong-Bing Zhao, Yihebali Chi, Lin Yang, Jing Jin. Efficacy and toxicity of capecitabine combined with intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancerWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1532-1543 doi: 10.4251/wjgo.v13.i10.1532
7
Sipan Keshishyan, Vikas Sehdev, David Reeves, Sidhartha D. Ray. A worldwide yearly survey of new data in adverse drug reactionsSide Effects of Drugs Annual 2015; 37: 567 doi: 10.1016/bs.seda.2015.08.009
8
Xiangdong Cheng, Yi Lu. A Review of Capecitabine-Based Adjuvant Therapy for Gastric Cancer in the Chinese PopulationFuture Oncology 2018; 14(8): 771 doi: 10.2217/fon-2017-0558